HomeTERN • NASDAQ
add
Terns Pharmaceuticals Inc
Previous close
$3.05
Day range
$2.84 - $3.06
Year range
$1.87 - $11.40
Market cap
254.91M USD
Avg Volume
1.23M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 25.95M | 7.86% |
Net income | -21.80M | -3.71% |
Net profit margin | — | — |
Earnings per share | -0.24 | 17.24% |
EBITDA | -25.88M | -7.91% |
Effective tax rate | -0.18% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 358.16M | 35.96% |
Total assets | 363.93M | 35.53% |
Total liabilities | 18.06M | 37.33% |
Total equity | 345.87M | — |
Shares outstanding | 87.30M | — |
Price to book | 0.77 | — |
Return on assets | -17.48% | — |
Return on capital | -18.20% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -21.80M | -3.71% |
Cash from operations | -14.58M | 24.50% |
Cash from investing | -94.35M | -299.75% |
Cash from financing | 304.00K | -97.81% |
Net change in cash | -108.70M | -358.60% |
Free cash flow | -9.12M | 22.44% |
About
Founded
2016
Headquarters
Website
Employees
59
